Results 191 to 200 of about 4,811,177 (246)

Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis. [PDF]

Clin Exp Med
Zhang A, Sun T, Yu D, Fu R, Liu X, Xue F, Liu W, Ju M, Dai X, Dong H, Gu W, Chen J, Chi Y, Li H, Wang W, Yang R, Chen Y, Zhang L.   +17 more
europepmc   +1 more source

The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis [PDF]

, 2016
Marko Lucijanić, Vlatko Pejša, Ozren Jakšić, Zdravko Mitrović, Čedna Tomasović‐Lončarić, Tajana Štoos‐Veić, Željko Prka, Mario Piršić, Višnja Hariš, Tamara Vasilj, Rajko Kušec   +10 more
openalex   +1 more source

Primary myelofibrosis: 2017 update on diagnosis, risk‐stratification, and management

American journal of hematology/oncology, 2016
A. Tefferi
semanticscholar   +1 more source

Case report: A case of effective treatment of primary myelofibrosis with nodular panniculitis using ruxolitinib combined with corticosteroids. [PDF]

Front Oncol
Wufuer G, Zhao JL, Huang Q, Babayi A, Abudureyimu D, Mao M, Duan MH.   +6 more
europepmc   +1 more source

Cardiac tamponade associated with primary myelofibrosis: a case report. [PDF]

Eur Heart J Case Rep
Widodo WA, Putra TMH, Elfiana M, Khorinal EW.   +3 more
europepmc   +1 more source

Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis

British Journal of Haematology, 2018
A. Tefferi, Sahrish H Shah, M. Mudireddy, T. Lasho, D. Barraco, C. Hanson, R. Ketterling, M. Elliott, M. Patnaik, A. Pardanani, N. Gangat   +10 more
semanticscholar   +1 more source

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

, 2014
Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Jelena D. Milosevic Feenstra, Ilaria Carola Casetti, Marta Bellini, Nicole C.C. Them, Chiara Cavalloni, Virginia Valeria Ferretti, Chiara Milanesi, Tiina Berg, Emanuela Sant’Antonio, Emanuela Boveri, Cristiana Pascutto, Cesare Astori, Róbert Královics, Mario Cazzola   +16 more
openalex   +1 more source

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

Drugs in Context, 2019
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Marisante Napolitano , Florinda Di Piazza, Antonio Russo, Sergio Mario Siragusa   +6 more
doaj   +1 more source

Cerebral venous sinus thrombosis associated with JAK2 V617F mutation-related pre-primary myelofibrosis: a case report and literature review. [PDF]

BMC Neurol
Song J, Huang C, Jia L, Wang M, Wu C, Ji X, Song H, Meng R, Zhou D.   +8 more
europepmc   +1 more source